CareDx (CDNA) news
Recent news
CareDx announces inducement grants under Nasdaq listing rule 5635(c)(4)
AInvest Wire · Jul 31, 2026CareDx Inc: Jefferies raises target price to $46 from $26
AInvest Wire · Jul 31, 2026CareDx outlook FY revenue USD 490-500 million
AInvest Wire · Jul 30, 2026CareDx Inc: BTIG raises target price to $45 from $28
BTIG has raised its price target for CareDx Inc (NASDAQ:CDNA) to $45 from $28, while maintaining a Buy rating, following favorable coverage determination . The stock is currently trading at $39.85, up 58% year-to-date and near its 52-week high of $40.38. The updated price target reflects the firm’s…
AInvest Wire · Jul 17, 2026Caredx's AlloMap, AlloSure heart coverage maintained by CMS
The Centers for Medicare & Medicaid Services (CMS) has reaffirmed coverage for Caredx's AlloMap and AlloSure heart tests, maintaining their inclusion in the Medicare national coverage determination for heart transplant monitoring. This decision ensures continued access for eligible patients and…
AInvest Wire · Jul 16, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.